|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||19.60 - 19.86|
|52 Week Range||14.27 - 24.64|
|Beta (5Y Monthly)||0.54|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.16 (0.79%)|
|Ex-Dividend Date||Jun 29, 2020|
|1y Target Est||N/A|
Blood pressure is one of the most important variables evaluated during almost every surgical intervention, but recent studies show that fluctuations in blood pressure may be missed due to standard intermittent readings.
NEW YORK, NY / ACCESSWIRE / October 16, 2020/ Getinge AB (OTCMKTS:GNGBY) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on October 16, 2020 at 10:00 AM Eastern Time.
Born 12 weeks too early with a 50/50 chance at survival, Sabina Checketts has grown up to become a neonatal doctor herself, using new therapies and sophisticated technology to improve outcomes for premature babies. One such technique called NAVA, invented by Getinge, utilizes sensors to help babies on ventilators breathe more easily and naturally-and it's increasingly being used on adults. And a new randomized study shows that NAVA can significantly shorten the time on the ventilator.